A promising vaccine target for the most deadly type of malaria has had its molecular structure solved by Institute researchers, helping in the quest to develop new antimalarial therapies.
A promising vaccine target for the most deadly type of malaria has had its molecular structure solved by Institute researchers, helping in the quest to develop new antimalarial therapies.